ERBB2 and lung cancer: This approach, when combined with human epidermal growth factor receptor 2 (HER2)-specific CAR-T-cell therapy, effectively eliminated 3D-cultured tumor spheroids in vitro and inhibited tumor growth in in vivo orthotopic lung cancer models [70].